Fig. 2From: Analysis of genetic biomarkers, polymorphisms in ADME-related genes and their impact on pharmacotherapy for prostate cancerSignal transmission through AR is the main pathway for prostate cancer cell growth and spread. Therefore, regulating androgen receptors (ARs) in cells is the key to many cancer-related genes. Testosterone or dehydroepiandrosterone is converted to dehydroepiandrosterone by 5 α reductase. DHT then dissociates HSP and AR to form a complex, which is transferred to the nucleus and activates cancer-associated genes. Androgens and androgen receptors (AR) in cells regulate cancer-related genes. It is possible to control human androgen-related malignant tumors by targeting androgen signaling pathways in tumor cells with anti-androgen, 5-α reductase inhibitors, heat shock protein 90 inhibitors, androgen receptor agonists, and serotonin inhibitorsBack to article page